Q: About a patient receiving Cholestyramine (LM-12)



Cholestyramine is used to reduce serum cholesterol because of its ability to interfere with the enterohepatic circulation of bile salts in the feces. When this drug is prescribed to a patient, which of the following compounds will be found in high concentrations in feces?


a) Doxycholate


b) Palmitate


c) Glucuronate


d) Bilirrubin


e) Squalen


f) estercobilinogen

Q: About the Total Oxidation of a Fatty Acid (LM-11)





 The number of moles of reduced cofactors produced by the complete oxidation of 1 mol of capric acid to CO2 and water will be closest to which of the following?


a) 5 moles of  FADH2 and 10 moles of NADH.H+


b) 10 moles of  FADH2 and 10 moles of NADH.H+


c) 10 moles of  FADH2 and 15 moles of  NADH.H+


d) 10 moles of  FADH2 and 20 moles of  NADH.H+


e) 20 moles of  FADH2 and 20 moles of  NADH.H+





About Fat Mobilization

 Question About Lipid Metabolism (LM-10)

Which one of the following enzymes is involved in the mobilization of fatty acids from triacyglyerol stores in adipose tissue?


a)     carnitin acyl transferase


b)     gastric lipase


c)      hormone sensitive lipase


d)     lipoprotein lipase


e)     pancreatic lipase


f)       phospholipase A2


g)     phospholipase C